Bulletins and Reports

  • Highlights from the American Society of Clinical Oncology (ASCO) Conference 2015
    • Download

      The Annual Meeting of the American Society of Clinical Oncology (ASCO) was held from May 29 to June 02, 2015, in Chicago, Illinois, the United States of America. The meeting served as a collaborative platform that brings together over 30,000 oncology professionals from around the world. 

      The scientific sessions comprised presentations on the latest ground-breaking research on various topics such as cancer prevention, genetics, epidemiology, developmental therapeutics, advanced treatment modalities, new therapies, ongoing controversies and health services and quality of care for a range of cancers. 

      In recent years, there has been an increasing interest in the ErbB family - HER2, EGFR, HER3 and Immuno-oncology checkpoint targets PD-1 and PD-L1, in various cancer populations at different stages from the early to the metastatic stage. This FSRC conference report sheds light on these most discussed therapeutic targets.

      Furthermore, the report also shares insights on health services research and quality of care, specifically issues related to access to care. The report highlights key areas like access-related issues on genomic testing, emergency diagnosis, cancer pain management, effects of cancer on quality of life, healthcare resource utilization and cost, social-ecological perspectives on care seeking patterns, improving veteran access and the role and use of technology for healthcare delivery.

  • Highlights form European Association for the Study of the Liver (EASL) - International Liver Congress (ILC) 2015
    • Download

      The FSRC conference report brings you excerpts from “European Association for the Study of the Liver (EASL) - International Liver Congress (ILC) 2015”, an event conducted in Vienna, Austria from April 22 to April 26, 2015. The event witnessed the participation of an array of delegates and ambassadors from across the globe. The year 2015 marked a very distinctive juncture for EASL and the Hepatology community as the event commemorated their golden jubilee of annual meetings, and also signified the accomplishment of three progressive decades by the Journal of Hepatology.

      The ILC 2015 conference focused on viral hepatitis, major infectious liver diseases, liver tumors, fatty liver disease, alcoholic liver disease and drug induced liver disease, autoimmune and chronic cholestatic liver disease, genetic and pediatric liver diseases and more.

      This FSRC conference report brings you a condensed overview of ILC 2015 focused on viral therapy for hepatitis C, especially from many landmark clinical trials that were conducted for the treatment of the disease. Apart from diagnosis, treatment and management of hepatitis C, the report also includes key points from the presentation discussing the delayed treatment involved in countering this ailment.

  • Highlights form the 8th International Conference on Advanced Technologies and Treatments for Diabetes
    • Download

      The 8th International Conference on Advanced Technologies and Treatments for Diabetes was held from February 18 to 21, 2015. The primary focus of the program was to provide a platform for sharing global research knowledge and experience and furnish participants with revolutionary insights into the latest developments in diabetes-related technology.

      Recently, there have been pioneering breakthroughs in the field of diabetes management such as insulin pump therapy, artificial pancreas, mobile apps and more and the conference threw light on these and more. The conference also was dominated by commonly addressed subjects such as technology supplementing diabetes management, especially self-management. There were further explorations with supporting studies that identified patients’ attitudes and perceptions on the use of these technologies to manage diabetes. The conference report gives a brief overview of the relevant areas covered.

  • Highlights from the 2014 World Cancer Congress
    • The 2014 World Cancer Congress was held from December 3rd – 6th in Melbourne, Australia. It had served as a platform for the exchange of innovative ideas and knowledge. In addition, it provided educational and training opportunities through master courses, networking, scientific sessions, symposia, discussion panels, debates, poster presentations, a media track and much more.

      In recent times, social media is fast becoming a key instrument in health promotion. The development of social media has fundamentally changed the way society communicates by facilitating networking and engagement. Social media provides a platform for the exchange of knowledge and expertise. In addition, it has become an asset for health care organizations and Non-Governmental Organizations (NGOs) to amplify health advocacy, thereby promoting health care access.  

      Some of the highlights of leveraging social media for cancer advocacy, awareness and prevention are captured in this conference report.

  • Access Issues for Colorectal Cancer: Resource Based Recommendations
    • Download

      Every 3.5 minutes, someone is diagnosed with colorectal cancer (CRC); every 9 minutes, someone dies from CRC; and every 5 seconds, someone who should be screened for CRC is not. Thus there is a need to understand the disease in an accurate manner and further, take required and adequate steps to manage the condition. With this as background, phamax invited key healthcare stakeholders from countries of various economic levels, to participate in a survey to investigate the burden imposed by CRC. The results of this was used as a basis to formulate recommendations based on the economic status of the countries involved.

  • KAP Survey: Impact of Oral Therapies for Viral Hepatitis in Emerging Countries
    • Download

      Despite the significant burden imposed by viral hepatitis and the excitement around the new oral therapies developed for it, insufficient attention has been paid to the healthcare access perspective of this disease. The findings of the survey show that key experts believe viral hepatitis is likely to remain a global burden as there exist barriers to care beyond simple drug price: factors such as local availability of drugs, lack of government focus, absence of advocacy, inappropriate or outdated guidelines, insufficient public awareness, and inadequate infrastructure and resources.

      As part of our continuing efforts to address healthcare access issues across the world, FSRC is considering a survey to assess the current knowledge, attitudes, and practices (KAP) involved in the management of viral hepatitis globally. As a preliminary step, a pilot KAP survey was fielded amongst key global stakeholders to investigate the need for a full-scale questionnaire on the burden imposed by hepatitis.

      FSRC’s extensive experience in these regions shows that solving these issues must be the primary focus for any stakeholders who aspire to improve the viral hepatitis situation in their country. Therefore, only a holistic approach that addresses the multitude of access barriers simultaneously is needed to control the growing burden of viral hepatitis.

  • World hepatitis day report 28th July, 2014
    • Download

      This report outlines the activities that were conducted on the event of World Hepatitis Day (28th July, 2014) by phamax, to improve awareness on hepatitis among urban and rural people. The intention was to improve hepatitis awareness by conducting sessions with key rural decision makers, who would serve as mediators in spreading the messages further, in the community. As a part of urban awareness activity, pamphlets were distributed in Koramangala, Bangalore to passersby highlighting the preventive aspects of hepatitis.

  • Hepatitis highlights from 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy and the 47th Annual Meeting of ESPGHAN
    • Download

      This FSRC conference report highlights the key hepatitis C (HCV)-related developments from the major international conferences held in May and June 2014. We focus on two conferences in particular: the 15th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy (Washington DC, USA) and the 47th Annual Meeting of ESPGHAN (Jerusalem, Israel). Overall, we report considerably increased attention on HCV during this time period, which also saw the release of the EASL Recommendations on Treatment of Hepatitis and the launch of the WHO’s first Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. Moreover, we describe some of the promising new drugs and treatment strategies currently in the pipeline for HCV management, including recent advances in therapy design and a novel microdose approach to treating HCV. Finally, we summarize the results of major clinical trials in healthy volunteers as well as in liver-transplant and chronic hepatitis patients (adolescents to adults).

  • Hepatitis C highlights from EASL - International Liver Congress ‘14
    • Download

      FSRC presents the conference report with highlights from the European Association for The Study of the Liver (EASL) - International Liver Congress ( ILC) 2014 that was held in London, UK from 9th to 13th April, attracting more than 10,000 experts worldwide. This conference report focuses on the results of many landmark clinical trials for the treatment of hepatitis C that were presented at the congress.

  • HCV Codex: an overview of epidemiology, clinical features and diagnosis
    • Download

      As per WHO estimates, currently over 500 million people globally are living with chronic viral hepatitis. Most of these people, who were infected long ago with HBV or HCV, are unaware of their chronic infection status due to benign nature of the disease in its early stages. FSRC is proud to present the HCV Codex as a part of its stated goals and aims to disseminate scientific information and create awareness on viral hepatitis.

  • A Short Survey on Choice of Information Preferred
    • Download

      Today, we live in a world of abundant information. Information lies in various formats like books, internet, mails, conferences and peer discussions. The problem with this information however is that the information is not sorted and presented in the format that the end user would like to consume it. Neither do the sources know how much the end user already knows. This leads to a lot of effort in sorting in a hay of disorganized data. We at FSRC share updates to you through mails, on social networks and through our website. Through this short survey we explore the preferred choice of information to facilitate us on making our future communications with you more relevant and enhanced.

  • Hepatitis C highlights from APASL annual meeting 14 and 4th ICVH
    • Download

      FSRC presents the conference report with highlights from the Asian Pacific Association for The Study of the Liver (APASL) annual meeting held from 12th to 15th March in Brisbane, Australia and the 4th International Conference on Viral Hepatitis (ICVH) held on March 17th and 18th 2014 in New York City, USA. The report focuses on viral hepatitis/HIV coinfection and hepatits C treatment and challenges.

  • Hepatitis C highlights from HEP DART ‘13 and 7th Paris Hepatitis conference
    • Download

      FSRC presents the conference report from the Hep Dart conference held on 12th and 13th December 2013 in Hawaii and 7th Paris Hepatitis Conference held on 13th and 14th January 2014 in Paris. The report focuses on the developments in the hepatitis C virus space.

  • World hepatitis day celebration at FSRC
    • Download

      FSRC conducted a scientific and awareness building initiative on the occasion of World Hepatitis Day. On the 26th of July a panel of experts from various facets of health delivery and management met to discuss and propose the recommendations that the government should look at for the control, prevention and management of chronic viral hepatitis in India. On the 29th of July, at the JyotiNivas College, a guest lecture on hepatitis awareness was delivered. We also conducted a pre-lecture survey on the KAPs of hepatitis in a college going audience.

  • Hepatitis Bulletin - 8th Edition
    • Download

      The 8th Edition of FSRC bulletin delivers CODEX that looks at the evolution of diagnostics for HCV. Also in this edition a write-up on occult hepatitis - Revealing the Occult, Cost of treatment – Still a challenge for Hepatitis C, country epidemiology report on Pakistan, profile of ‘The National Organisation for People Living with Hepatitis B (NOPLHB), Uganda’ and daclatasvir under the pipeline molecule section. This edition’s info-graphic is a comparison between HIV/AIDS and hepatitis along with news around hepatitis.

  • Hepatitis Bulletin - 7th Edition
    • Download

      The 7th Edition of the FSRC bulletin deliberates on the possibility of ‘Getting to Zero’ with hepatitis. Also featuring in the edition are the now common features such as the CODEX, country specific epidemiology report, profile of a promising drug and updates on the hepatitis space across the globe. Other highlights are the detailed hepatitis awareness survey and promising drugs for HIV/HCV co-infections.

  • Hepatitis Bulletin - 6th Edition
    • Download

      The 6th Edition of the FSRC bulletin covers World Hepatitis Day events conducted by the group. Also featuring in the edition are a continuation to codex with a look into the genotypes of HCV, an India specific infographic and an epidemiology report on the country for HCV, an interesting pipeline report on sofosbuvir and updates on the hepatitis space across the globe under the news section of the bulletin.

  • Hepatitis Bulletin - 5th Edition
    • Download

      The fifth edition of the bulletin continues the Codex section that provides a detailed report on transmission of hepatitis C and a comparison of this facet of the disease with other forms of hepatitis. Additionally, information on global HCV infection prevalence and genotype distribution has been presented in the form of an infographic. As a follow-up to the previous edition, we bring you coverage of ‘The 63rd Annual Meeting of the American Association for the Study of Liver Diseases’, held in Boston in November 2012, with an emphasis on existing therapies. Finally, updates on the hepatitis space across the globe are highlighted in the news section of the bulletin.

  • Hepatitis Bulletin - 4th Edition
    • Download

      Along with a change in the look and feel, we also make a slight deviation from our usual style to outline the risk of HCV infection among healthcare workers and measures to prevent it. Included is an infographic on  Clinical application and drug development  in HCV. The activities at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases has been covered with a focus on  New agents in HCV . The HCV Codex continues with a focus on the  Natural history and Clinical features of Hepatitis C Infection  and news from around the world impacting hepatitis.

  • Hepatitis Bulletin - 3rd Edition
    • Download

      A guest article from Dr. Gerd Bodlaj on "Chronic Hepatitis C - the Austrian experience" is the highlight of the third bulletin. We bring coverage on the "New Anti-Viral Therapies Sessions - Abstract and Posters" presented during the  19th International Symposium on Hepatitis C Virus and Related Viruses  held in Venice, Italy. The HCV Codex in this issue focuses on Global Prevalence of HCV. Also featured is our routine coverage of news from around the world impacting the hepatitis space.

  • Hepatitis Bulletin - 2nd Edition
    • Download

      The second edition of the Hepatitis bulletin features an article from our HCV expert Prof. David Goldberg from Scotland. He shares  The Scottish Experience  of drawing out a successful action plan for HCV in Scotland. We initiate the HCV Codex in this edition and focus on an overview of HCV. Also in this edition are the first-hand experiences of the FSRC team in a HCV screening program in Austria and a write-up on Hepatitis Hilfe Österreich, the association of the month. Along with these, we have results from the survey conducted on HCV Awareness.

  • Hepatitis Bulletin - 1st Edition
    • Download

      The first issue of FSRC Hepatitis bulletin focuses on the recognition of Hepatitis as a burden by WHO and the allocation of Hepatitis Day. We look at the events that were planned for this occasion in 2012. World Hepatitis Alliance, a NGO focusing on patients with hepatitis is profiled and their work in the field outlined. Finally news are included in the hepatitis space from across the globe.